Patient Guide: A Clinical Study to Assess the Efficacy and Safety of Alpha DaRT224 for the Treatment of Patients With Recurrent Cutaneous Squamous Cell Carcinoma

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 31 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05323253
Status: 🟢 Enrolling Now
Condition: Recurrent Squamous Cell Carcinoma
Phase: NA

Where You Can Participate

This study is available at 31 locations across the country.

Top locations include:
  • • Gilbert, Arizona
  • • Phoenix, Arizona
  • • Phoenix, Arizona
  • • And 28 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Clinical Study to Assess the Efficacy and Safety of Alpha DaRT224 for the Treatment of Patients With Recurrent Cutaneous Squamous Cell Carcinoma - Join Clinical Trial NCTNCT05323253

How to Join This Clinical Trial - NCTNCT05323253

Learn how to participate in this NA trial studying an investigational therapy for Recurrent Squamous Cell Carcinoma. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Recurrent Squamous Cell Carcinoma. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Recurrent Squamous Cell Carcinoma
Treatment Being Tested
Investigational treatment
Study Phase
NA - Research study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT05323253 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 31 locations. Find a study site near you:

Clinical Research Site

Gilbert, Arizona 85234 - United States

Status: RECRUITING

Clinical Research Site

Phoenix, Arizona 85004 - United States

Status: RECRUITING

Clinical Research Site

Phoenix, Arizona 85032 - United States

Status: RECRUITING

Clinical Research Site

Los Angeles, California 90095 - United States

Status: RECRUITING

Clinical Research Site

DeLand, Florida 32720 - United States

Status: RECRUITING

Clinical Research Site

Delray Beach, Florida 33445 - United States

Status: RECRUITING

Clinical Research Site

Delray Beach, Florida 33484 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Delray Beach, Florida 33484 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Hollywood, Florida 33021 - United States

Status: RECRUITING

Clinical Research Site

Miami, Florida 33101 - United States

Status: RECRUITING

And 21 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this NA clinical trial for Recurrent Squamous Cell Carcinoma:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships